It is estimated that around 2 billion people are anemic worldwide, and The World Health Organization (WHO) recognize it as a “significant global public-health problem affecting both developing and developed countries.”
The condition is characterized by a low concentration of hemoglobin in the blood, impairing quality of life and potentially leading to additional health complications or life-threatening conditions. A report from the WHO reveal that women and preschool-aged children are particularly affected, and in developed countries, there is a high prevalence of anemia among the elderly.
Though anemia is a complex disorder with multiple types and causes, it can be diagnosed easily with the help of thorough medical history, clinical examination and laboratory tests. However, this process can be time consuming, and in resource-limited settings these tests may be too expensive or not be available at all. Further, major challenges in such settings include poor infrastructure, lack of human capacity and laboratory policies, compromising the quality of test results.
AnemiPoint, developed by Eva Diagnostics, is an affordable, handheld anemia diagnostic device offering a quantitative and robust solution with laboratory accuracy. Using a single drop of blood from a finger prick, it enables healthcare workers to measure haemoglobin and haematocrit with an analysis time of only 30 seconds.
The device is designed to minimize user errors and to work in any healthcare setting around the world. It can perform 400 measurements on a single charge and is not affected by power shortages. It is sustainable, with no reagents required, meaning it can be a powerful diagnostic tool in remote, resource-limited settings.
With its special focus on resource-limited settings, AnemiPoint won People's Choice Award at the Saving Lives at Birth Competition, which is backed by the Bill and Melinda Gates Foundation, USAID and UK Aid. The device was also touted as one of the seven most promising technologies in UK by the Telegraph. The company Eva Diagnostics was the winner of the 2014 European Grand Prize at OneStart, the world’s largest businessplan competition.